TLR7 and Miyoshi myopathy: Even though the pDC response is largely heterogeneous in human subjects, we found a reduced fraction of IFN-α-producing pDCs after stimulation with TLR-7 agonists (i.e., resiquimod and imiquimod), in chemo-naïve MM patients.